Diabetic women treated with alendronate had increases in bone mineral density of the spine and hip and at all sites. Fosamax, a drug used to increase bone mineral density in older women, works well for women with type 2 diabetes, according to a new report.
Read More »Bone Is A Target For Rosiglitazone
Rosiglitazone administration results in significant bone loss.
Read More »The Link Between Diabetes and Bone Density/Osteoporosis
Fifty years since it was demonstrated that diabetes is associated with loss of bone mass.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.